Oncogene - Table of Contents alert Volume 30 Issue 41

TABLE OF CONTENTS Volume 30, Issue 41 (October 2011) In this issue Original Articles Short Communication Also new AOP Advertisment Can I really get the confidence I need to find genetic variants? Sure You Can, with the new Agilent SureScan Microarray Scanner. Our new compact system for cytogenetic research applications provides the resolution required to detect copy number changes or copy neutral aberrations. Click here for a special offer and to learn more. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take a look at this recent article published in Cancer Gene Therapy: Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs FREE Y Horikawa, Wang, S Nagano, J Kamizono, M Ikeda et al Cancer Gene Therapy doi:10.1038/cgt.2011.44   Original Articles Top P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism S Al-Bahlani, M Fraser, A Y C Wong, B S Sayan, R Bergeron, G Melino and B K Tsang Oncogene 2011 30: 4219-4230; advance online publication, April 25, 2011; 10.1038/onc.2011.134 Abstract | Full Text Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer M Musumeci, V Coppola, A Addario, M Patrizii, M Maugeri-Saccà, L Memeo, C Colarossi, F Francescangeli, M Biffoni, D Collura, A Giacobbe, L D'Urso, M Falchi, M A Venneri, G Muto, R De Maria and D Bonci Oncogene 2011 30: 4231-4242; advance online publication, May 2, 2011; 10.1038/onc.2011.140 Abstract | Full Text Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours N Rajan, R Elliott, O Clewes, A Mackay, J S Reis-Filho, J Burn, J Langtry, M Sieber-Blum, C J Lord and A Ashworth Oncogene 2011 30: 4243-4260; advance online publication, May 9, 2011; 10.1038/onc.2011.133 Abstract | Full Text Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional G Lossaint, E Besnard, D Fisher, J Piette and V Dulić Oncogene 2011 30: 4261-4274; advance online publication, May 2, 2011; 10.1038/onc.2011.135 Abstract | Full Text CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation D Gerstel, F Wegwitz, K Jannasch, P Ludewig, K Scheike, F Alves, N Beauchemin, W Deppert, C Wagener and A K Horst Oncogene 2011 30: 4275-4288; advance online publication, May 2, 2011; 10.1038/onc.2011.146 Abstract | Full Text Short Communication Top Shared acquired genomic changes in zebrafish and human T-ALL L A Rudner, K H Brown, K P Dobrinski, D F Bradley, M I Garcia, A C H Smith, J M Downie, N D Meeker, A T Look, J R Downing, A Gutierrez, C G Mullighan, J D Schiffman, C Lee, N S Trede and J K Frazer Oncogene 2011 30: 4289-4296; advance online publication, May 9, 2011; 10.1038/onc.2011.138 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.